RE:RE:RE:Phase 2 study InquiryRumpl3StiltSkin wrote: StevenBirch wrote: I think they have learned a lot since the first lockdown last spring and maybe most importantly is that there are other illnesses and medical emergencies that are a priority also. I would be very disappointed if they had to delay again for various reasons and I think that is just speculation at this point.
Case in point, they are testing a treatment/vaccine for covid and we don't hear anything? So I wouldn't take silence as a delay rather just a lack of urgency by the company to keep us informed.
VentureGuy24 wrote: Are we enrolling and treating patients? Has covid wave 2 caused another delay? This company has been very silent on all fronts. I fear our trial just got extended again.
I'm expecting some great news out of TLT soon, maybe this month still. Something from Dr. Coombs. Some CR data from Phase 2. If they are both good then we may see that .50c number fall pretty damn quick.
Hey RSS... still happily & patiently waiting for in-vivo small animal results re: our compound's efficacy against BSL-3 SARS-CoV-2 (virus causing Covid-19)....my timeline puts results coming out by end of Q1, then off to human trials...."subject to suitable financing" per the NR. Crossing my fingers that "suitable financing" comes in the form of a grant or a wealthy partner. The preclinical evidence continues to grow re: the efficacy of PDT against various enveloped viruses, including the one causing Covid-19.
Based on the fact that our compound has demonstrated (preclinically) a superior form of DAMP-mediated immunogenic cell death (which augments its direct cytotoxic/anti-cancer effects), one can reasonably assume that our compound will have the clinical ability to unleash pathogen-associated molecular patterns (PAMPs), stimulating superior immunity against enveloped viruses (like SARS-CoV-2, Flu, Zika, etc). Imo, the production of these PAMPs via treatment of viruses with TLD-1433/PDT could potentially replace a commonly used anti-viral vaccine production method, which uses a non-ionic detergent to solubilize the virions. This latter method may lead to a less specific/effective anti-viral vaccine.
Now add to the above our compound's anti-Covid therapeutic potential : )...a little nasal/upper airway therapeutic spray or rinse for early or mild illness, & an inhaled version for more advanced or lower airway disease....potentially with or without PDT.
My bad for being off topic ; ). Best of luck Longs!